SE8305323L - Prostaglandinderivat - Google Patents

Prostaglandinderivat

Info

Publication number
SE8305323L
SE8305323L SE8305323A SE8305323A SE8305323L SE 8305323 L SE8305323 L SE 8305323L SE 8305323 A SE8305323 A SE 8305323A SE 8305323 A SE8305323 A SE 8305323A SE 8305323 L SE8305323 L SE 8305323L
Authority
SE
Sweden
Prior art keywords
prostaglandine
prostaglandin derivative
effect
derivatives
prostaglandines
Prior art date
Application number
SE8305323A
Other languages
English (en)
Swedish (sv)
Other versions
SE8305323D0 (sv
SE448872B (sv
Inventor
S Enomoto
K Asano
H Tamura
H Tanaka
Original Assignee
Kureha Chemical Ind Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP53009652A external-priority patent/JPS5850236B2/ja
Priority claimed from JP10443478A external-priority patent/JPS5845440B2/ja
Application filed by Kureha Chemical Ind Co Ltd filed Critical Kureha Chemical Ind Co Ltd
Publication of SE8305323D0 publication Critical patent/SE8305323D0/xx
Publication of SE8305323L publication Critical patent/SE8305323L/
Publication of SE448872B publication Critical patent/SE448872B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
    • C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00—Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J1/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, not substituted in position 17 beta by a carbon atom, e.g. estrane, androstane
    • C07J1/0051—Estrane derivatives
    • C07J1/0066—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa
    • C07J1/007—Estrane derivatives substituted in position 17 beta not substituted in position 17 alfa the substituent being an OH group free esterified or etherified
    • C07J1/0074—Esters

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
SE8305323A 1978-01-31 1983-09-29 Fodelsebefremjande medel innehallande ett konjugat av en prostaglandin med ett steroidhormon SE448872B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP53009652A JPS5850236B2 (ja) 1978-01-31 1978-01-31 プロスタグランジン類↓−ステロイドホルモン結合体
JP10443478A JPS5845440B2 (ja) 1978-08-29 1978-08-29 プロスタグランジン誘導体とその製造方法及び薬剤

Publications (3)

Publication Number Publication Date
SE8305323D0 SE8305323D0 (sv) 1983-09-29
SE8305323L true SE8305323L (sv) 1983-09-29
SE448872B SE448872B (sv) 1987-03-23

Family

ID=26344419

Family Applications (5)

Application Number Title Priority Date Filing Date
SE7900086A SE441006B (sv) 1978-01-31 1979-01-04 Konjugat av en prostaglandin med ett steroidhormon
SE8305324A SE448873B (sv) 1978-01-31 1983-09-29 Kontraceptivt medel innehallande ett konjugat av en prostaglandin med ett steroidhormon
SE8305321A SE448870B (sv) 1978-01-31 1983-09-29 Forfarande for framstellning av ett konjugat av en prostaglandin med ett steroidhormon
SE8305322A SE448871B (sv) 1978-01-31 1983-09-29 Abortmedel innehallande ett konjugat av en prostaglandin med ett steroidhormon
SE8305323A SE448872B (sv) 1978-01-31 1983-09-29 Fodelsebefremjande medel innehallande ett konjugat av en prostaglandin med ett steroidhormon

Family Applications Before (4)

Application Number Title Priority Date Filing Date
SE7900086A SE441006B (sv) 1978-01-31 1979-01-04 Konjugat av en prostaglandin med ett steroidhormon
SE8305324A SE448873B (sv) 1978-01-31 1983-09-29 Kontraceptivt medel innehallande ett konjugat av en prostaglandin med ett steroidhormon
SE8305321A SE448870B (sv) 1978-01-31 1983-09-29 Forfarande for framstellning av ett konjugat av en prostaglandin med ett steroidhormon
SE8305322A SE448871B (sv) 1978-01-31 1983-09-29 Abortmedel innehallande ett konjugat av en prostaglandin med ett steroidhormon

Country Status (16)

Country Link
US (1) US4198405A ( )
AR (1) AR223473A1 ( )
AU (1) AU519132B2 ( )
CA (1) CA1125742A ( )
CH (1) CH639668A5 ( )
DE (1) DE2900061C2 ( )
DK (1) DK159455C ( )
ES (1) ES477216A1 ( )
FI (1) FI68811C ( )
FR (1) FR2422686A1 ( )
GB (1) GB2015528B ( )
IL (1) IL56430A ( )
IT (1) IT1110751B ( )
NL (1) NL187485C ( )
NO (1) NO151087C ( )
SE (5) SE441006B ( )

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4318908A (en) * 1979-12-06 1982-03-09 Kureha Kagaku Kogyo Kabushiki Kaisha Methylated prostaglandin derivatives
US4784960A (en) * 1981-09-24 1988-11-15 Peter S. Brune Process for preparation of control for use in progesterone receptor
US4423151A (en) * 1981-09-24 1983-12-27 Peter S. Brune Process for preparation of control for use in estrogen receptor tests
NL8105635A (nl) * 1981-12-15 1983-07-01 Univ Erasmus Geneesmiddel met transplantaatafstotings- en/of immunologische ontstekingsremmende werking, alsmede werkwijze voor de remming van transplantaatafstoting en/of immunologische ontsteking.
DE3337450A1 (de) * 1983-10-12 1985-04-25 Schering AG, 1000 Berlin und 4709 Bergkamen Prostaglandine und antigestagene fuer den schwangerschaftsabbruch
US20070191320A1 (en) * 1998-12-10 2007-08-16 Nexmed Holdings, Inc. Methods of treatment for female sexual arousal disorder
US6486207B2 (en) 1998-12-10 2002-11-26 Nexmed (Holdings), Inc. Compositions and methods for amelioration of human female sexual dysfunction
US6825234B2 (en) 1998-12-10 2004-11-30 Nexmed (Holdings) , Inc. Compositions and methods for amelioration of human female sexual dysfunction
EP1641462B1 (en) * 2003-07-03 2010-11-24 Sucampo AG Enteric coated composition comprising prostaglandin analogs as chloride channel opener
US7067505B2 (en) * 2004-01-15 2006-06-27 Warner Chilcott Company, Inc. Di-steroidal prodrugs of estradiol
CA2553816A1 (en) * 2004-01-15 2005-08-04 Warner Chilcott Company, Inc. Di-steroidal prodrugs of ethinyl estradiol
WO2007024338A2 (en) * 2005-07-12 2007-03-01 Warner Chilcott Company, Inc. 3 -ester prodrugs of ethynylestradiol
CA2610481A1 (en) * 2005-07-12 2007-01-18 Warner Chilcott Company, Inc. 3-ester prodrugs of estradiol
WO2021220061A2 (en) * 2020-05-01 2021-11-04 Ripple Therapeutics Corporation Heterodimer compositions and methods for the treatment of ocular disorders

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3839409A (en) * 1958-05-28 1974-10-01 Kemiska Inst Karolinska I Pge3 esters and alkanoates
US3732261A (en) * 1971-12-03 1973-05-08 Nelson Res & Dev Steroid compounds
JPS5829318B2 (ja) * 1974-03-11 1983-06-22 オノヤクヒンコウギヨウ カブシキガイシヤ プロスタグランジンルイジカゴウブツ ホウホウ

Also Published As

Publication number Publication date
SE448873B (sv) 1987-03-23
SE8305323D0 (sv) 1983-09-29
IL56430A0 (en) 1979-03-12
CH639668A5 (de) 1983-11-30
AR223473A1 (es) 1981-08-31
SE8305321D0 (sv) 1983-09-29
GB2015528A (en) 1979-09-12
AU519132B2 (en) 1981-11-12
NL187485B (nl) 1991-05-16
NO151087B (no) 1984-10-29
US4198405A (en) 1980-04-15
NO790297L (no) 1979-08-01
GB2015528B (en) 1982-10-27
FR2422686A1 (fr) 1979-11-09
AU4254578A (en) 1979-08-09
FI68811C (fi) 1985-11-11
SE8305324D0 (sv) 1983-09-29
SE8305324L (sv) 1983-09-29
FI790281A (fi) 1979-08-01
ES477216A1 (es) 1980-03-01
SE7900086L (sv) 1979-08-01
SE441006B (sv) 1985-09-02
FI68811B (fi) 1985-07-31
DE2900061C2 (de) 1982-04-01
FR2422686B1 ( ) 1982-11-19
CA1125742A (en) 1982-06-15
SE8305322D0 (sv) 1983-09-29
NL187485C (nl) 1991-10-16
SE448871B (sv) 1987-03-23
DK6179A (da) 1979-08-01
DE2900061A1 (de) 1979-08-02
IT1110751B (it) 1986-01-06
NO151087C (no) 1985-02-06
SE8305322L (sv) 1983-09-29
IL56430A (en) 1984-03-30
DK159455C (da) 1991-03-18
IT7919091A0 (it) 1979-01-05
NL7900071A (nl) 1979-08-02
DK159455B (da) 1990-10-15
SE448870B (sv) 1987-03-23
SE8305321L (sv) 1983-09-29
SE448872B (sv) 1987-03-23

Similar Documents

Publication Publication Date Title
SE8305321L (sv) Prostaglandinderivat
NO791116L (no) Hjerteventil-protese.
BR7602955A (pt) Cadeira articulada
NL184875C (nl) Aderkatheterverband.
NL7606233A (nl) Kunstmatige gewrichtskom.
SE7606302L (sv) Uppresningsstol, speciellt hopfellbar uppresninsstol for invalider och sjuka
NL7903715A (nl) Sok.
DK147647C (da) Selvdrevet, pneumatisk jordslagbor
SE7802054L (sv) Hjertventilprotes
DK140583B (da) Operationsstol for en behandlende læge.
FR2298303A1 (fr) Chaise hygienique ou chaise percee
IT7829207A0 (it) Preparati farmaceutici.
FR2322580A1 (fr) Prothese de valvule cardiaque
BE849196A (fr) Derives de l'argininamide, leur preparation et leurs utilisation therapeutiques
ATA55279A (de) Mehrteiliger, feuerfester isolierformkoerper
NL7708561A (nl) Bereiding van een proteine voedingsprodukt.
BE876513A (fr) Chaise
SE7807408L (sv) Hjertaktiva foreningar
BE857576A (fr) Derives de la phenothiazine, leur preparation et leurs utilisations therapeutiques
IT7924364A0 (it) Preparati farmaceutici con aumentata azione ipotensiva.
NL7902170A (nl) Prostaglandine-analoga.
MA19290A1 (fr) Derives du benzole,leur preparaton et leur utilisations therapeutiques .
IT7831198A0 (it) Derivato isossazolico,ad attivita'terapeutica
SE7611125L (sv) Hjertaktiva foreningar
BE882734A (fr) Derives de 16-methoxy-16-methyl prostaglandine e1, leur preparation et leur utilisation

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 8305323-1

Effective date: 19920806

Format of ref document f/p: F